25884947|t|Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
25884947|a|Mutations in the valosin containing protein (VCP) gene cause hereditary Inclusion body myopathy (hIBM) associated with Paget disease of bone (PDB), frontotemporal dementia (FTD), more recently termed multisystem proteinopathy (MSP). Affected individuals exhibit scapular winging and die from progressive muscle weakness, and cardiac and respiratory failure, typically in their 40s to 50s. Histologically, patients show the presence of rimmed vacuoles and TAR DNA-binding protein 43 (TDP-43)-positive large ubiquitinated inclusion bodies in the muscles. We have generated a VCPR155H/+ mouse model which recapitulates the disease phenotype and impaired autophagy typically observed in patients with VCP disease. Autophagy-modifying agents, such as rapamycin and chloroquine, at pharmacological doses have previously shown to alter the autophagic flux. Herein, we report results of administration of rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, and chloroquine, a lysosomal inhibitor which reverses autophagy by accumulating in lysosomes, responsible for blocking autophagy in 20-month old VCPR155H/+ mice. Rapamycin-treated mice demonstrated significant improvement in muscle performance, quadriceps histological analysis, and rescue of ubiquitin, and TDP-43 pathology and defective autophagy as indicated by decreased protein expression levels of LC3-I/II, p62/SQSTM1, optineurin and inhibiting the mTORC1 substrates. Conversely, chloroquine-treated VCPR155H/+ mice revealed progressive muscle weakness, cytoplasmic accumulation of TDP-43, ubiquitin-positive inclusion bodies and increased LC3-I/II, p62/SQSTM1, and optineurin expression levels. Our in vitro patient myoblasts studies treated with rapamycin demonstrated an overall improvement in the autophagy markers. Targeting the mTOR pathway ameliorates an increasing list of disorders, and these findings suggest that VCP disease and related neurodegenerative multisystem proteinopathies can now be included as disorders that can potentially be ameliorated by rapalogs. 
25884947	0	9	Rapamycin	Chemical	MESH:D020123
25884947	14	25	chloroquine	Chemical	MESH:D002738
25884947	115	141	valosin containing protein	Gene	7415
25884947	142	167	multisystem proteinopathy	Disease	MESH:C563476
25884947	186	212	valosin containing protein	Gene	7415
25884947	214	217	VCP	Gene	7415
25884947	230	264	hereditary Inclusion body myopathy	Disease	MESH:C536816
25884947	266	270	hIBM	Disease	MESH:C536816
25884947	288	309	Paget disease of bone	Disease	MESH:D010001
25884947	311	314	PDB	Disease	MESH:D010001
25884947	317	340	frontotemporal dementia	Disease	MESH:D057180
25884947	342	345	FTD	Disease	MESH:D057180
25884947	369	394	multisystem proteinopathy	Disease	MESH:C563476
25884947	396	399	MSP	Disease	MESH:C563476
25884947	473	488	muscle weakness	Disease	MESH:D018908
25884947	494	525	cardiac and respiratory failure	Disease	MESH:D012131
25884947	574	582	patients	Species	9606
25884947	624	650	TAR DNA-binding protein 43	Gene	23435
25884947	652	658	TDP-43	Gene	23435
25884947	742	750	VCPR155H	ProteinMutation	tmVar:p|SUB|R|155|H;HGVS:p.R155H;VariantGroup:0;CorrespondingGene:7415;RS#:121909329;CorrespondingSpecies:9606;CA#:128983
25884947	753	758	mouse	Species	10090
25884947	852	860	patients	Species	9606
25884947	866	877	VCP disease	Disease	MESH:D011488
25884947	915	924	rapamycin	Chemical	MESH:D020123
25884947	929	940	chloroquine	Chemical	MESH:D002738
25884947	1066	1075	rapamycin	Chemical	MESH:D020123
25884947	1105	1136	mechanistic target of rapamycin	Gene	56717
25884947	1138	1142	mTOR	Gene	56717
25884947	1167	1178	chloroquine	Chemical	MESH:D002738
25884947	1308	1316	VCPR155H	ProteinMutation	tmVar:p|SUB|R|155|H;HGVS:p.R155H;VariantGroup:0;CorrespondingGene:7415;RS#:121909329;CorrespondingSpecies:9606;CA#:128983
25884947	1319	1323	mice	Species	10090
25884947	1325	1334	Rapamycin	Chemical	MESH:D020123
25884947	1343	1347	mice	Species	10090
25884947	1471	1477	TDP-43	Gene	230908
25884947	1567	1570	LC3	Gene	66734
25884947	1577	1580	p62	Gene	18412
25884947	1581	1587	SQSTM1	Gene	18412
25884947	1589	1599	optineurin	Gene	71648
25884947	1650	1661	chloroquine	Chemical	MESH:D002738
25884947	1670	1678	VCPR155H	ProteinMutation	tmVar:p|SUB|R|155|H;HGVS:p.R155H;VariantGroup:0;CorrespondingGene:7415;RS#:121909329;CorrespondingSpecies:9606;CA#:128983
25884947	1681	1685	mice	Species	10090
25884947	1707	1722	muscle weakness	Disease	MESH:D018908
25884947	1752	1758	TDP-43	Gene	230908
25884947	1810	1813	LC3	Gene	66734
25884947	1820	1823	p62	Gene	18412
25884947	1824	1830	SQSTM1	Gene	18412
25884947	1836	1846	optineurin	Gene	71648
25884947	1879	1886	patient	Species	9606
25884947	1918	1927	rapamycin	Chemical	MESH:D020123
25884947	2004	2008	mTOR	Gene	56717
25884947	2094	2105	VCP disease	Disease	MESH:D011488
25884947	2118	2163	neurodegenerative multisystem proteinopathies	Disease	MESH:C563476
25884947	Positive_Correlation	MESH:D002738	18412
25884947	Negative_Correlation	MESH:D002738	MESH:D018908
25884947	Association	MESH:C536816	7415
25884947	Association	MESH:D057180	RS#:121909329;HGVS:p.R155H;CorrespondingGene:7415
25884947	Positive_Correlation	MESH:D002738	71648
25884947	Association	MESH:D011488	RS#:121909329;HGVS:p.R155H;CorrespondingGene:7415
25884947	Positive_Correlation	MESH:D002738	66734
25884947	Negative_Correlation	MESH:D020123	18412
25884947	Association	MESH:C563476	7415
25884947	Association	MESH:D010001	7415
25884947	Comparison	MESH:D002738	MESH:D020123
25884947	Negative_Correlation	MESH:D020123	MESH:D011488
25884947	Negative_Correlation	MESH:D002738	RS#:121909329;HGVS:p.R155H;CorrespondingGene:7415
25884947	Association	MESH:D057180	7415
25884947	Negative_Correlation	MESH:D020123	71648
25884947	Association	MESH:C563476	56717
25884947	Association	MESH:D011488	56717
25884947	Negative_Correlation	MESH:D020123	230908
25884947	Negative_Correlation	MESH:D020123	56717
25884947	Negative_Correlation	MESH:D020123	66734
25884947	Association	MESH:D057180	7415
25884947	Association	MESH:D011488	7415

